glp-1 news today october 9 2025 Who Gets the Shot? Access by State Regulating a "Miracle Drug": GLP-1

Covering a GLP-1 weight-loss drug and a neuropathy medication under the same Medicare plan is achievable for most patients - but the two drugs travel through separate systems and are not reviewed together

You will also see an intentional boundary between information and action

Some individuals discontinue with plans to restart if regain becomes excessive

Mechanistic studies showed that stattic suppressed RANKL-induced MDSCs by blocking STAT3 and NF-B signaling

Platelets, a key cell in inflammation and atherosclerosis progression

People who are obese (have a BMI greater than or equal to 30) are clinically eligible for GLP-1 drugs, but employer plans may set additional BMI requirements to cover GLP-1 drug use under obesity